Why Pfizer Stock and This Covid Vaccine Partner Are Falling on Earnings

Pfizer beats earnings forecasts for the second quarter, while BioNTech's results miss expectations due to weak Covid vaccine demand.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。